Citations

Clear

183 citation(s) found for "Sher-Lu, P".

Abstract 4367606: Racial, Gender, and Regional Disparities in Peripheral Arterial Disease–Related Mortality Among Hypertensive Adults in the United States: A 1999–2020 CDC WONDER Analysis
Ijaz, Muhammad Tayyab , Ubaid, Muhammad Furqan, Asif, Anim , Mukhtar, Haseeb , Ijaz, Namra, Haider, Zaroon, Altin, Elissa, Ijaz, Namra, Haider, Zaroon, Khan, Sher

Mayo Clinic

Circulation | November 3, 2025 | Volume: 152 | Issue: Suppl_3 | Pages: No page available

10.1161/circ.152.suppl_3.4367606 Get It

Introduction: Peripheral Arterial Disease (PAD) is a prevalent condition associated with considerable morbidity and mortality, a burden that is further intensified by the frequent co-occurrence of hypertension. The coexistence of these conditions not only amplifies cardiovascular risks but also complicates clinical management, thereby contributing to elevated mortality rates. Although their correlation is well understood, mortality trends in United States have not been studied. Methods: This study utilized International Classification of Diseases, 10th Revision (ICD-10) codes to extract age-adjusted mortality data for individuals with PAD and hypertension from the CDC WONDER (Center for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research) cohort. The overall sample and subgroups defined by demographics (age, sex, race/ethnicity) and region (state, census and urban-rural status) were analyzed. Trends in mortality were quantified by computing associated annual percentage changes (APC) using Joinpoint Regression Program Version 4.9.0.0 trend analysis software. Results: A total of 540954 deaths were observed, of which 260517 were men (48.2%). Overall, the age-adjusted mortality rates (AAMR) exhibited a sharp increase from 1999 to 2001 (APC:25.3; 95% CI: -0.36,56.2), followed by a sustained decrease until 2017 (APC: -2.16; 95% CI: -11.1, -1.52), after which a notable upward trend was observed (APC:9.38; 95% CI: -0.38,24.1). A similar AAMR trend was seen on gender-based subgroup analysis with male patients showing the highest AAMR 13.5 (95% CI: 13.1,13.7) in 2020. Amongst all racial groups, Black or African American showed the highest 14.9 (95% CI: 14.8-15) while Asian or Pacific Islander showed the lowest 5.8 (95% CI: 5.7-5.9) AAMR over 2 decades. The West region had the highest overall age-adjusted mortality rate (AAMR) of 10.2 (95% CI: 10.2-10.3). Among individual states, Vermont displayed the highest AAMR, reaching 15.8 (95% CI: 15.1-16.5). Conclusion: Healthcare disparities are evident. The unprecedented recent increase in mortality rates, following years of successful decline, necessitates a thorough evaluation of healthcare policies and PAD treatment advancements to identify the causative factors behind this trend reversal.
Assessment of Gastric Content Using Gastric Ultrasound in Patients on Glucagon-Like Peptide-1 Receptor Agonists Before Anesthesia
Pai, Sher‐Lu , Nimma, Sindhuja, Beam, William B. , VanderWielen, Beth A. , Bettini, Layne M., Collaborators, MAGIC (Mayo Anesthesia Gastric Imaging Collaborative), Logvinov, Ilana I. , Nimma, Sindhuja R, Beam, W Brian, Kalagara, Hari K., Yu, Soojie , Pai, Sher-Lu , Logvinov, Ilana , Kalagara, Hari , Sharpe, Emily E. , Harbell, Monica W. , Collaborators, MAGIC (Mayo Anesthesia Gastric Imaging Collaborative)

Mayo Clinic

Anesthesia & Analgesia | October 1, 2025 | Volume: 142 | Issue: 4 | Pages: 640-649

10.1213/ane.0000000000007764 | PMID 41032460 Get It

BACKGROUND: The use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) has significantly increased in recent years. GLP-1 RAs delay gastric emptying, resulting in early satiety and weight loss. This may increase the risk of pulmonary aspiration of residual gastric contents (RGC) during anesthesia delivery. Evidence is urgently needed to guide perioperative anesthesia management for patients taking GLP-1 RAs. This study evaluated preoperative factors that may be associated with high RGC. METHODS: Adult patients who were taking GLP-1 RAs and scheduled to receive anesthesia at 3 hospitals between June 30, 2023, and August 15, 2024, were evaluated via preoperative point-of-care gastric ultrasonography (GUS). The primary outcome was high RGC, defined by the presence of solids food or >1.5 mL/kg of clear liquids on GUS, and its association with preoperative factors (eg, existing medical conditions, indication and route of taking GLP-1 RAs, length of taking GLP-1 RAs, days of withholding GLP-1 RAs before surgery, and preoperative fasting periods). Data are presented as median (interquartile range [IQR]). RESULTS: Among the 316 patients (60.9 years [52.1–68.9] of age; 167 [52.8%] females) included in the study, 113 (35.8%) had high RGC. A higher percentage (5.3%; 6/113) of patients in the high RGC group had an opioid prescription for pain management within 3 months of the GUS assessment compared to the low RGC group (1.0%; 2/203; P = .027). No statistical difference was found between the groups in other existing medical conditions, indication and route of taking GLP-1 RAs, and length of taking GLP-1 RAs. Of the 294 patients taking weekly injections, there were 187 (63.6%) with low RGC and 107 (36.4%) with high RGC. Patients with low RGC withheld their GLP-1 RAs for 8 days [5–10], while patients with high RGC withheld for 6 days [3–9] ( P = .003). Receiver operating characteristic (ROC) analysis found ≤7.5 days of withholding the medication as cutoff for increased prevalence of high RGC in patients taking GLP-1 RA injections. Patients with low RGC fasted from solid food for 20.0 hours [14.8–40.8], and patients with high RGC fasted from solid food for 15.0 hours [12.8–19.0] ( P < .001). ROC found ≤21.3 hours of fasting from solid food as the cutoff for increased prevalence of high RGC. CONCLUSIONS: GLP-1 RA usage may delay gastric emptying. In preoperatively fasting adults, ≤7.5 days of withholding injections and ≤21.3 hours of fasting from solid food are associated with high RGC.
Intracardiac thrombosis and its management during liver transplantation: international, multicenter, case-control study
Prete, Luca Del , Cazzaniga, Beatrice , Aniskevich, Stephen , Agopian, Vatche G. , Smith, Natalie , Cacioppo, Brian J, Nuti, Anna Maria, Wang, Ryan , Gamboa, Bs Sophia, Groose, Molly K. , Sheth, Mansi, Cywiński, Jacek B. , Wray, Christopher , Hashimoto, Koji , Liu, Qiang , Quintini, Cristiano , Del Prete, Luca , Agopian, Vatche G , Smith, Natalie K , Tu, Chao , Groose, Molly K , Cywinski, Jacek B , Nguyen-Buckley, Christine , Florman, Sander S , Liu, Qiang , Ekser, Burcin , Aniskevich, Stephen , Cacioppo, Brian J., Watson, Christopher, Pai, Sher‐Lu , Nguyen, Christine , Florman, Sander , Croome, Kristopher P. , Ekser, Burcin

Mayo Clinic

International Journal of Surgery | August 22, 2025 | Volume: 111 | Issue: 12 | Pages: 8793-8805

10.1097/js9.0000000000002896 | PMID 40844270 Get It

Background: Intracardiac thrombosis (ICT) during liver transplantation (LT) is a rare but life-threatening complication with limited data regarding its risk factors, management, and outcomes. This study aimed to identify factors associated with ICT development, define predictors of intraoperative outcomes, and propose a novel classification and management algorithm for ICT. Methods: A multicenter, international retrospective case-control study was conducted on liver transplant recipients from seven centers between January 2005 and December 2023. ICT cases were identified through transesophageal echocardiography (TEE) or autopsy and matched 1:1 with controls. Results: Among 11 077 liver transplant recipients screened, 133 patients (1.2%) developed ICT. ICT occurred predominantly after reperfusion (58%). Compared to controls, ICT cases exhibited higher preoperative international normalized ratio ( P = 0.001) and fibrinogen levels ( P = 0.014). Post-reperfusion syndrome ( P < 0.001), disseminated intravascular coagulation ( P < 0.001), and primary graft failure ( P = 0.002) were also more common in the ICT group. Continuous veno-venous hemofiltration during surgery (odds ratio [OR] 8.20, 95% confidence interval [CI]: 2.09–38.1; P = 0.004) was associated with ICT development. ICT was associated with markedly higher rates of cardiac arrest ( P < 0.001) and intraoperative mortality ( P < 0.001), with thrombus location in the left heart chambers representing a significant predictor of mortality (OR 20.7, 95% CI: 6.25–81.3; P < 0.001). ICT grades 2 and 3 were associated with a markedly increased risk of intraoperative cardiac arrest ( P < 0.05). Importantly, delayed use of TEE was strongly associated with intraoperative death (OR 6.27, 95% CI: 1.45–27.1; P = 0.014). The 90-day mortality was 43% in ICT cases compared to 4.5% in controls, while 1-year mortality was 46% versus 10.5%, respectively. Conclusions: ICT during LT is a rare but severe complication associated with intraoperative mortality and poor short-term survival. Coagulation profile and intraoperative management play critical roles in ICT development. The early use of TEE enables timely diagnosis and intervention, improving patient outcomes. We propose a novel ICT classification offering a systematic framework for risk stratification and management to mitigate progression and mortality.
Cultural Influences, Considerations, and Challenges for Organ Donation and Liver Transplantation Around the World
Pai, Sher‐Lu , Izzy, Manhal , Chieh, Alfred Kow Wei, Montasser, Iman Fawzy , Kemmer, Nyingi , Yoon, Uzung , Giorgakis, Emmanouil , Lunsford, Keri E. , Becchetti, Chiara , Feier, Flávia Heinz , Montenovo, Martin I. , Andaçoğlu, Oya , Montasser, Iman F , Selzner, Nazia , Lunsford, Keri E , Becchetti, Chiara , Feier, Flávia Heinz , Darwish Murad, Sarwa , Montenovo, Martin , Aguilera, Victoria , Pai, Sher-Lu , Giorgakis, Emmanouil , Selzner, Nazia , Murad, Sarwa Darwish

Mayo Clinic

Clinical Transplantation | July 24, 2025 | Volume: 39 | Issue: 8 | Pages: No page available

10.1111/ctr.70252 | PMID 40704567 Get It

ABSTRACT Introduction Although liver transplantation (LT) rates have increased globally, the demand for organs still exceeds the supply. This review highlights cultures with significant influences on organ donation and LT. Methods We performed a literature search for articles related to cultures, ethnologies, philosophies, policies, religions, socio‐economic factors, and other influences affecting organ donation in LT around the world. Results There are astonishing similarities between different cultures. In Africa, Asia, and Europe, people often view the postmortem bodies as sacred and believe that their bodies are gifts from “God” or ancestors. To respect the gift of life, to have a chance in reincarnation, or to enjoy life after death, many believe that their bodily sanctity must be preserved. In Asia, Europe, and Latin America, there is a general reluctance to speak about death. Religions also play an important role in people's views on organ donation. Different regions around the world have similar challenges to organ donation, such as misconceptions about organ trafficking, political and economic instability, and a lack of governmental or religious support. Conclusion Addressing the complexities of organ donation and LT requires a multifaceted approach. Culturally sensitive education tailored to diverse communities can dispel myths and misconceptions surrounding organ donation. Fostering partnerships between healthcare providers, religious leaders, community organizations, and policymakers can further facilitate open dialogues and promote organ donation as a noble act to save lives. Social Media Similar cultures around the world post challenges for organ donation. Organizations should foster partnerships between healthcare providers, politicians, and religious leaders to promote donation.
Navigating the clinical benefits, risks, and emerging controversies with glucagon-like peptide-1 receptor agonists
Sen, Sudipta , Pai, Sher‐Lu , Harbell, Monica W.

Mayo Clinic

Current Opinion in Anaesthesiology | June 10, 2025 | Volume: 38 | Issue: 4 | Pages: 533-539

10.1097/aco.0000000000001522 | PMID 40493797 Get It

Purpose of review: The purpose of this review is to provide an overview of the current clinical implications, benefits, and controversies surrounding the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs). This review discusses the potential risks associated with GLP-1 RA therapy, such as pulmonary aspirations, tachyphylaxis, and issues with drug efficacy over time. Furthermore, it examines the increasing ethical and medical concerns related to their off-label use, safety, and accessibility. Recent findings: Recent studies highlight significant discrepancies in the recommendations provided by different medical societies on the perioperative management of GLP-1 RAs. In addition, insurance barriers exacerbate access issues, with substantial disparities in coverage for weight loss versus diabetes management. The rise of counterfeit GLP-1 RAs, unintentional overdoses, and the growing concern about long-term health impacts are also prominent challenges in the current landscape. Summary: Despite increasing usage and the potential benefits of GLP-1 RAs, a lack of consensus on optimal perioperative management and long-term use, coupled with financial and regulatory barriers, creates significant challenges. Medical societies differ on key aspects such as fasting requirements and the risk of aspiration, and concerns about the safety of compounded and counterfeit products remain.
Standardizing the Definition of Each Colon Cancer Segment: Delphi Consensus on Clinical Decision-Making for Oncologic Outcomes
Kuzu, Mehmet Ayhan , Parvaiz, Amjad , Görgün, Emre , Wexner, Steven D. , Dozois, Eric J. , Hohenberger, Werner , Mišković, Danilo , Sugihara, Kenichi , Spinelli, Antonino , Wiggers, Theo , Basany, Eloy Espin, Uriburu, Juan C Patrón , Perez, Rodrigo Oliva , Lynch, Craig, Liu, Zheng , Chowdri, Nisar Ahmad , Madoff, Robert D. , West, Nick P, Şahin, Turgut , Bordeianou, Liliana , Group, On behalf of the Colon Cancer Delphi Consensus Study, Koh, Cherry , Perry, William , Park, Ji Won , Spinelli, Antonino , Wexner, Steven D , Perry, William R , Gaertner, Wolfgang B. , Benlice, Çiğdem , Bertelsen, Claus Anders , Lee, Woo-Yong , Möslein, Gabriela , Владимирович, Царьков Петр , Basany, Eloy Espin, Hahnloser, Dieter , Nilsson, Per Johan , Brown, Gina , Rouanet, Philippe , West, Nick P, Elhan, Atilla Halil , Group, On behalf of the Colon Cancer Delphi Consensus Study

Mayo Clinic

Diseases of the Colon & Rectum | April 11, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/dcr.0000000000003739 | PMID 40214091 Get It

BACKGROUND: Data registries lack a definitive classification system that distinguishes different locations of colon cancer from one another. OBJECTIVE: To establish an international consensus on the definition of primary colon cancer segment locations. DESIGN: Between December 2022 and June 2023, Delphi survey study was conducted to seek opinions from relevant international experts and eventually develop a consensus definition of each colon cancer segment. SETTING: Three-round online-based Delphi survey study. INTERVENTIONS: Online survey included 17 questions. In the first two rounds, participating experts were asked to rank each statement on a scale of 1–9 (9 is the most relevant). Consensus statements and definitions were revised according to results, obtaining a consensus score of 7–9. During the third round and online meeting, definitions and statements reached a moderate or high consensus(above 4 in more than 70% of participants) were included. MAIN OUTCOME AND MEASURE: Primary goal of our project was focused on precisely localizing the specific segment affected by primary colon cancer, rather than to identify surgical treatment or type of resection needed for particular segment. RESULTS: The first round included 331 experts, 301 (91%) completed the second round, and 295 (98%) completed the final round. Experts strongly supported the use of a “10 cm rule” to describe colon cancer sites at the flexures and anatomical landmarks for other segments. Regarding the definition of rectosigmoid cancer, experts from America and Europe reached a high consensus that the term rectosigmoid as a colon cancer location must be abolished in contrast to experts from Asia. Description of cancers overlapping segments achieved a consensus of 64%. LIMITATIONS: Subjective decisions are based on individual expert clinical experience. CONCLUSIONS: This Delphi survey, the first internationally conducted consensus study, achieved a remarkable level of consensus among a panel of global experts. Ambiguity still exists regarding overlapping lesions. See Video Abstract .
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part I
León, José de , Baldessarini, Ross J. , Balon, Richard , Bilbily, John , Citrome, Leslie , Cotes, Robert O. , Davis, John M. , DeLisi, Lynn E. , Faden, Justin , Freudenreich, Oliver , Goldsmith, David R. , Gurrera, Ronald J. , Josiassen, Richard C. , Kelly, Deanna L. , Laitman, Robert S., Lam, Y. W. Francis , Love, Raymond C. , McCollum, Betsy , Meyer, Jonathan M. , Nasrallah, Henry A. , Nucifora, Frederick C. , Rothschild, Anthony J. , Shelton, Charles , Sher, Leo , Zarzar, Theodore R. , Sanz, Emílio J. , Cuevas, Carlos De las , de Leon, Jose , Caroff, Stanley N , Citrome, Leslie , Correll, Christoph Ulrich , Cotes, Robert O , Davis, John M , Faden, Justin , Freudenreich, Oliver , Gurrera, Ronald , Kane, John M , Laitman, Robert S , Lam, Y W Francis , Leung, Jonathan G , Love, Raymond C , McCollum, Betsy , McGrane, Ian , Meyer, Jonathan M , Nasrallah, Henry A , Rothschild, Anthony J , Rubio, Jose M , Sarpal, Deepak K , Schoretsanitis, Georgios , Shad, Mujeeb , Shelton, Charles , Sher, Leo , Singh, Balwinder , Surya, Sandarsh , Zarzar, Theodore R , Sanz, Emilio J , De Las Cuevas, Carlos , Kane, John M. , Keshavan, Matcheri S. , Leung, Jonathan G. , McGrane, Ian R. , Sajatovic, Martha , Schoretsanitis, Georgios , Singh, Balwinder

Mayo Clinic

Journal of Clinical Psychopharmacology | April 8, 2025 | Volume: 45 | Issue: 3 | Pages: 179-196

10.1097/jcp.0000000000001987 | PMID 40198781 Get It

Abstract Purpose/Background Clozapine was approved in the United States (US) using 1989 regulations and knowledge. After 30 years, many sections of the US package insert (PI) are outdated. Methods We comprehensively reviewed the literature to propose PI updates. We present the information in 2 articles. In Part I, we focus on basic pharmacology based on 407 relevant articles. Part II focuses on clinical aspects and pharmacovigilance. Findings/Results Based on more recent expectations of Food and Drug Administration regulations, we reviewed clozapine basic pharmacology including the following: 1) clearance, 2) pharmacokinetics and pharmacodynamics, and 3) monitoring tools. We identified 9 major problems in the basic pharmacological sections of the PI including the following: 1) in vivo studies indicate that clozapine is dependent on CYP1A2 for its metabolism, 2) the minor role of CYP2D6 in clozapine metabolism requires removing the PI recommendation to lower clozapine doses in CYP2D6 poor metabolizers, 3) in nontoxic concentrations CYP3A4 has a minor role in clozapine metabolism and potent CYP3A4 inhibitors lack clinically relevant effects, 4) several drug-drug interactions need to be updated based on recent literature, 5) systemic inflammation may decrease clozapine metabolism and increase the risk of clozapine intoxication, 6) obesity may decrease clozapine metabolism, 7) patients of Asian and Indigenous American ancestry need lower clozapine doses, 8) personalized titration and c-reactive protein monitoring should be considered until prospective studies are available, and 9) the half-life section needs to be modified to acknowledge that single dosing at night is frequent in the US. Implications/Conclusions An improvement in the US clozapine PI may lead to improvement in PIs worldwide.
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part II
León, José de , Baldessarini, Ross J. , Balon, Richard , Bilbily, John , Citrome, Leslie , Cotes, Robert O. , Davis, John M. , DeLisi, Lynn E. , Faden, Justin , Freudenreich, Oliver , Goldsmith, David R. , Gurrera, Ronald J. , Josiassen, Richard C. , Kelly, Deanna L. , Laitman, Robert S., Lam, Y. W. Francis , Love, Raymond C. , McCollum, Betsy , Meyer, Jonathan M. , Nasrallah, Henry A. , Nucifora, Frederick C. , Rothschild, Anthony J. , Shelton, Charles , Sher, Leo , Zarzar, Theodore R. , Sanz, Emílio J. , Cuevas, Carlos De las , de Leon, Jose , Caroff, Stanley N , Citrome, Leslie , Correll, Christoph Ulrich , Cotes, Robert O , Davis, John M , Faden, Justin , Freudenreich, Oliver , Gurrera, Ronald , Kane, John M , Laitman, Robert S , Lam, Y W Francis , Leung, Jonathan G , Love, Raymond C , McCollum, Betsy , McGrane, Ian , Meyer, Jonathan M , Nasrallah, Henry A , Rothschild, Anthony J , Rubio, Jose M , Sarpal, Deepak K , Schoretsanitis, Georgios , Shad, Mujeeb , Shelton, Charles , Sher, Leo , Singh, Balwinder , Surya, Sandarsh , Zarzar, Theodore R , Sanz, Emilio J , De Las Cuevas, Carlos , Kane, John M. , Keshavan, Matcheri S. , Leung, Jonathan G. , McGrane, Ian R. , Sajatovic, Martha , Schoretsanitis, Georgios , Singh, Balwinder

Mayo Clinic

Journal of Clinical Psychopharmacology | April 8, 2025 | Volume: 45 | Issue: 3 | Pages: 197-218

10.1097/jcp.0000000000001990 | PMID 40198784 Get It

Abstract Purpose/Background This is the second part of a 2-part article that proposes improving the United States (US) clozapine package insert. Part II focuses on fatal outcomes and the 5 boxed warnings, 4 specifically for clozapine: severe neutropenia, seizure, orthostatic hypotension and myocarditis, and 1 for all antipsychotics (elderly with dementia). Methods US reports to the World Health Organization's global pharmacovigilance database were analyzed from clozapine's introduction to January 15, 2023. Findings/Results The US was the top reporter worldwide for clozapine with 56,003 reports and 9587 associated fatal outcomes. The 4 clozapine boxed warnings were associated with 534 fatal outcomes (218 with severe neutropenia, 131 with seizures, 125 with orthostasis, 36 with myocarditis, 24 with cardiomyopathy, and 0 with mitral valve prolapse). With no boxed warnings, pneumonia was associated with 674 fatal outcomes and increased white blood cell count (a sign of infection) with 596 fatal outcomes. After considering overlaps, pneumonia and increases in white blood cell count explained 900 fatalities, or 9.4% of 9587 fatal outcomes. The Food and Drug Administration continues to focus on severe neutropenia which was associated with only 218 or 2.3% of fatal outcomes, whereas 97.7% of fatal outcomes reported in US clozapine-treated patients had another cause. Implications/Conclusions To help prevent future deaths in clozapine-treated patients, the clozapine package insert should focus on fatal outcomes during infections. Part II offers detailed solutions regarding current boxed warnings and lack of a warning for pneumonia and other infections. The Supplementary Material includes letters of support from 124 non-US clozapine experts from 44 countries/regions who support Parts I and II.
NCCN Guidelines® Insights: Head and Neck Cancers, Version 2.2025
Pfister, David G. , Spencer, Sharon A., Adkins, Douglas, Birkeland, Andrew C. , Busse, Paul M., Durm, Greg Andrew , Fakhry, Carole , Galloway, Thomas J. , Geiger, J.L. , Gillison, Maura L. , Haddad, Robert I. , Hitchcock, Ying J. , Jimeno, Antonio , Leizman, Debra S., Maghami, Ellie, Mell, Loren K. , Pinto, Harlan A. , Price, Katharine A. , Rocco, James W. , Rodriguez, Cristina P. , Sher, David J. , Wang, He , Weinstein, Gregory S., Yom, Sue S. , Zhen, Weining, Darlow, Susan, Price, Katharine, Haddad, Robert , Yom, Sue S , Colevas, Alexander Dimitrios , Cmelak, Anthony J. , Adkins, Douglas, Brizel, David M. , Caudell, Jimmy J , Glastonbury, Christine M. , Hicks, Wesley L. , Juloori, Aditya , Kase, Michael, Mittal, Bharat B. , Schwartz, David A. , Shah, Jatin P. , John, Maie A. St. , Worden, Francis P. , Bruce, Justine Y. , Montgomery, Sarah E.

Mayo Clinic

Journal of the National Comprehensive Cancer Network | February 12, 2025 | Volume: 23 | Issue: 2 | Pages: 2-11

10.6004/jnccn.2025.0007 | PMID 39938471 Get It

The NCCN Guidelines for Head and Neck Cancers address tumors arising in the oral cavity (including mucosal lip), pharynx, larynx, and paranasal sinuses, as well as occult primary cancer, salivary gland cancer, and mucosal melanoma (MM). The specific site of disease, stage, and pathologic findings guide treatment (eg, the appropriate surgical procedure, radiation targets, dose and fractionation of radiation, indications for systemic therapy). The NCCN Head and Neck Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel’s most recent recommendations regarding management of nasopharynx cancer and ongoing research in this area.